Building successful life sciences companies.

With over $200 million of committed capital under management, Genesys is one of the largest Canadian-based exclusively focused on the life sciences industry. View our portfolio.

Building companies, accelerating development.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Investor Login

Sign in to our secure investor area to receive personalized updates and information. Login now »

Recent Additions

Former Naurex Team Launches New Spin-Out Company, Aptinyx
Evanston, Ill., September 16, 2015 - Aptinyx Inc., a biopharmaceutical company advancing modulators of the N-methyl-D-aspartate (NMDA) receptor for... Read more
Allergan to Acquire Naurex
DUBLIN, IRELAND and EVANSTON, IL - July 26, 2015 - Allergan plc (NYSE: AGN), a leading global pharmaceutical company,... Read more